← All organizations
Highest phase reached
Phase 1
First clinical trial
Oct 1, 2015Last known activity
Dec 14, 2022
Timeline
2000s
- Jun 1, 2003
SillaJen, Inc.— Founded
2010s
- Mar 1, 2014
Jennerex Inc.— Acquired
Drugs by trial phase (7 distinct, 14 trials)
Phase 3 (0 own, 2 via acquisition)
Phase 2 (0 own, 1 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (6)
- NCT05768932Lead sponsorPhase 1Dec 14, 2022
- NCT05768932Study directorPhase 1Dec 14, 2022
- NCT03294083Study directorPhase 1Jun 7, 2018
- NCT03294083Lead sponsorPhase 1Jun 7, 2018
- NCT02562755Lead sponsorPhase 3Oct 1, 2015
- NCT02562755Study directorPhase 3Oct 1, 2015
Details
- Founded
- San Francisco, CA, US Jun 1, 2003
- Last known activity
- Dec 14, 2022